Antituberculosis medication as a possible epigenetic factor of Leber's hereditary optic neuropathy

Clinical and Experimental Ophthalmology

Volumn 38, Issue 4, 2010, Pages 363-366

  Seo, Je Hyun ^a,b   Hwang, Jeong Min ^a,c   Park, Sung Sup ^a  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University Biomedical Research Institute   (South Korea)

^c Seoul National University Bundang Hospital   (South Korea)

Author keywords

Antituberculosis medication; Epigenetic factor; Leber's hereditary optic neuropathy

Indexed keywords

ETHAMBUTOL; ISONIAZID; MITOCHONDRIAL DNA; NUCLEOTIDE; PYRAZINAMIDE; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; EPIGENETICS; FEMALE; HUMAN; LEBER HEREDITARY OPTIC NEUROPATHY; MALE; MEDICAL RECORD REVIEW; MUTATIONAL ANALYSIS; OPTIC NERVE DISEASE; VISUAL ACUITY; VISUAL IMPAIRMENT;

ADOLESCENT; ADULT; ANTITUBERCULAR AGENTS; CHILD; DNA, MITOCHONDRIAL; DRUG ADMINISTRATION SCHEDULE; EPIGENESIS, GENETIC; ETHAMBUTOL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HUMANS; MALE; MUTATION; OPTIC ATROPHY, HEREDITARY, LEBER; RETROSPECTIVE STUDIES; VISUAL ACUITY; YOUNG ADULT;

EID: 77954644769     PISSN: 14426404     EISSN: 14429071     Source Type: Journal    
DOI: 10.1111/j.1442-9071.2010.02240.x     Document Type: Article

References (15)

1. Newman NJ. Hereditary optic neuropathies. Walsh and Hoyt's Clinical Neuro-Ophthalmology 1998, 742-53. Miller NRNewman NJ. In, eds., 5th, edn., Baltimore, MD, Williams & Wilkins
2. Sadun AA, Carelli V, Salomao SR. Extensive investigation of large Brazilian pedigree of Italian ancestry (SOA-BR) with 117788/Haplogroup J Leber's Hereditary Optic Neuropathy (LHON). Am J Ophthalmol 2003, 136:231-8.
3. Chowdhury B, Nagpaul AK, Chowdhury D. Leber's hereditary optic neuropathy masquerading ethambutol-Induced optic neuropathy in a young male. Indian J Ophthalmol 2006, 54:218-19.
4. Dotti MT, Plewnia K, Cardaioli E. A case of ethambutol-induced optic neuropathy harbouring the primary mitochondrial LHON mutation at nt 11778. J Neurol 1998, 245:302-3.
5. Fukami S, Fujie W, Wakakura M. Characteristic feature of Leber's hereditary optic neuropathy in women. Rinsho Ganka 2003, 57:427-30.
6. Ikeda A, Ikeda T, Ikeda N. Leber's hereditary optic neuropathy precipitated by ethambutol. Jpn J Ophthalmol 2006, 50:280-3.
7. Marinis MD. Optic neuropathy after treatment with anti-tuberculous drugs in a subject with Leber's hereditary optic neuropathy mutation. J Neurol 2001, 248:818-19.
8. Kim JY, Hwang JM, Park SS. Mitochondrial DNA C4171A/ND1 is a novel primary causative mutation of Leber's hereditary optic neuropathy with a good prognosis. Ann Neurol 2002, 51:630-4.
9. Kim JY, Hwang JM, Chang BL, Park SS. Spectrum of the mitochondrial DNA mutations of Leber's hereditary optic neuropathy in Koreans. J Neurol 2003, 250:278-81.
10. Shin YJ, Park KH, Hwang JM. A new color vision test to differentiate congenital and acquired color vision defects. Ophthalmology 2007, 114:1341-7.
11. Sadun AA. Metabolic optic neuropathies. Semin Ophthalmol 2002, 17:29-32.
12. Yoon YH, Jung KH, Sadun AA. Ethambutol-induced vacuolar changes and neuronal loss in rat retinal culture: mediation by endogenous zinc. Toxicol Appl Pharmacol 2000, 162:107-14.
13. Warner JE, Ries KM. Optic neuropathy in a patient with AIDS. J Neuroophthalmol 2001, 21:92-4.
14. Shaikh S, Ta C, Basham AA, Mansour S. Leber hereditary optic neuropathy associated with antiretroviral therapy for human immunodeficiency virus infection. Am J Ophthalmol 2001, 131:143-5.
15. Mackey DA, Fingert JH, Luzhansky JZ. Leber's hereditary optic neuropathy triggered by antiretroviral therapy for human immunodeficiency virus. Eye 2003, 17:312-17.